Access count of this item: 111

Files in This Item:
File Description SizeFormat 
29_0095.pdf384.79 kBAdobe PDFView/Open
Title: 泌尿器科領域におけるCefmenoxime(CMX)の臨床的検討
Other Titles: Clinical study on cefmenoxime (CMX) in urology
Authors: 田中, 寛  KAKEN_name
加藤, 禎一  KAKEN_name
柿木, 宏介  KAKEN_name
西尾, 正一  KAKEN_name
前川, 正信  KAKEN_name
辻田, 正昭  KAKEN_name
西島, 高明  KAKEN_name
柏原, 昇  KAKEN_name
甲野, 三郎  KAKEN_name
早原, 信行  KAKEN_name
Author's alias: Tanaka, Hiroshi
Kato, Yoshikazu
Kakinoki, Kosuke
Nishio, Shoichi
Maekawa, Masanobu
Tsujita, Masaaki
Nishijima, Takaaki
Kashihara, Noboru
Kono, Saburo
Hayahara, Nobuyuki
Keywords: Adult
Cefotaxime/administration & dosage/analogs & derivatives/metabolism/therapeutic use
Cystitis/drug therapy
Drug Evaluation
Infusions, Parenteral
Middle Aged
Time Factors
Issue Date: Jan-1983
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 29
Issue: 1
Start page: 95
End page: 103
Abstract: Cefmenoxime (CMX)について,基礎的ならびに臨床的検討を行った.1.健康成人4名に対しCMX250 mgをcross over法を用いて,筋注,静注および1時間の点滴静注の3方法で投与した.各投与法における最高血中濃度(時間),血中半減期はそれぞれ,筋注5.9±0.1 μg/ml(30分),1.41時間,静注11.1±1.2 μg/ml(15分),1.26時間,1時間の点滴静注12.4±1.4(点滴静注終了時)0.94時間であった(いずれもMean±S.E.).またCMXの投与後6時間までの尿中排泄率は,いずれも60~70%であった.2.急性単純性膀胱炎4例に対するCMXの有効率は100%であった.3.複雑性尿路感染症10例に対する有効率は70%であった.無効例はいずれもカテーテル留置例でPseudomonasが存続もしくは菌交代として出現したものであった.なお従来のcephalosporin系抗生剤に耐性のSerratiaが陰性化した.4. CMX投与による自覚的副作用は認められなかった.しかし一過性に軽度のtransaminaseの上昇が1例にみられた
Basic and clinical studies were made on Cefmenoxime (CMX), a new cephalosporin antibiotic, and the following results were obtained. The serum concentration of CMX was examined in four healthy adults after administration of 250 mg of CMX by intramuscular injection, intravenous injection and one-hour intravenous drip infusion (cross over). In the case of intramuscular injection, the peak value of 5.9 micrograms/ml was obtained 30 minutes after administration, and the half-life in serum was 1.41 hours. In the case of intravenous drip infusion, injection, a concentration value of 11.1 micrograms/ml on the average was obtained after 15 minutes of administration, and the half-life in serum was 1.26 hours. In the case of intravenous drip infusion, the concentration was 12.4 micrograms/ml upon completion of drip infusion, and CMX disappeared from serum at a half-life of 0.94 hour. The urinary recovery up to 6 hours was from 60 to 70% in each The efficacy rate of this preparation was 100% for 4 cases of acute simple cystitis. The efficacy rate of CMX was 70% for 10 cases of complicated urinary tract infection; the 3 cases in which CMX was not effective were patients with a residual catheter and Pseudomonas persisting or appearing as superinfection. It was noted that Serratia, which was resistant to the conventional cephalosporin antibiotics, became negative. No subjective side effects due to the administration of this preparation were observed. As for abnormal laboratory findings, a slight and transient rise in transaminases was observed in one case. On the basis of the above-mentioned results, it was concluded that CMX is an effective preparation for the treatment of urinary tract infections.
PubMed ID: 6328956
Appears in Collections:Vol.29 No.1

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.